nodes	percent_of_prediction	percent_of_DWPC	metapath
Glyburide—ALB—liver cancer	0.156	1	CbGaD
Glyburide—ABCC1—Epirubicin—liver cancer	0.0814	0.163	CbGbCtD
Glyburide—ABCC3—Doxorubicin—liver cancer	0.0704	0.141	CbGbCtD
Glyburide—ABCB11—Doxorubicin—liver cancer	0.0609	0.122	CbGbCtD
Glyburide—ABCC2—Sorafenib—liver cancer	0.0528	0.105	CbGbCtD
Glyburide—ABCG2—Sorafenib—liver cancer	0.0477	0.0953	CbGbCtD
Glyburide—ABCC1—Doxorubicin—liver cancer	0.0432	0.0864	CbGbCtD
Glyburide—ABCB11—bile canaliculus—liver cancer	0.0423	0.337	CbGeAlD
Glyburide—ABCC2—Doxorubicin—liver cancer	0.032	0.0639	CbGbCtD
Glyburide—ABCG2—Doxorubicin—liver cancer	0.0289	0.0578	CbGbCtD
Glyburide—ABCC2—bile canaliculus—liver cancer	0.0215	0.171	CbGeAlD
Glyburide—CYP2C19—Sorafenib—liver cancer	0.0213	0.0426	CbGbCtD
Glyburide—CYP2C9—Sorafenib—liver cancer	0.0177	0.0354	CbGbCtD
Glyburide—ABCB1—Sorafenib—liver cancer	0.0172	0.0344	CbGbCtD
Glyburide—ABCB11—bile duct—liver cancer	0.0132	0.105	CbGeAlD
Glyburide—ABCB1—Doxorubicin—liver cancer	0.0104	0.0208	CbGbCtD
Glyburide—CYP3A4—Sorafenib—liver cancer	0.0103	0.0206	CbGbCtD
Glyburide—ABCB11—bile—liver cancer	0.0102	0.0809	CbGeAlD
Glyburide—ABCC3—bile duct—liver cancer	0.00841	0.067	CbGeAlD
Glyburide—ABCC2—bile duct—liver cancer	0.00672	0.0535	CbGeAlD
Glyburide—CYP3A4—Doxorubicin—liver cancer	0.00625	0.0125	CbGbCtD
Glyburide—ABCC2—bile—liver cancer	0.00516	0.0411	CbGeAlD
Glyburide—Allergic cutaneous angiitis—Sorafenib—liver cancer	0.00408	0.0669	CcSEcCtD
Glyburide—CFTR—gall bladder—liver cancer	0.00344	0.0274	CbGeAlD
Glyburide—Leukocytoclastic vasculitis—Sorafenib—liver cancer	0.00264	0.0434	CcSEcCtD
Glyburide—Lactic acidosis—Epirubicin—liver cancer	0.00196	0.0322	CcSEcCtD
Glyburide—Lactic acidosis—Doxorubicin—liver cancer	0.00182	0.0298	CcSEcCtD
Glyburide—ABCC3—gall bladder—liver cancer	0.00179	0.0143	CbGeAlD
Glyburide—ABCC9—liver—liver cancer	0.00157	0.0125	CbGeAlD
Glyburide—ALB—gall bladder—liver cancer	0.00153	0.0122	CbGeAlD
Glyburide—Bezafibrate—PPARA—liver cancer	0.00133	0.248	CrCbGaD
Glyburide—CPT1A—liver—liver cancer	0.00114	0.00912	CbGeAlD
Glyburide—Gliclazide—VEGFA—liver cancer	0.00113	0.212	CrCbGaD
Glyburide—Hepatic function abnormal—Sorafenib—liver cancer	0.00108	0.0177	CcSEcCtD
Glyburide—ABCA1—liver—liver cancer	0.00107	0.00849	CbGeAlD
Glyburide—Hepatic failure—Sorafenib—liver cancer	0.00105	0.0172	CcSEcCtD
Glyburide—Myelosuppression—Epirubicin—liver cancer	0.00102	0.0168	CcSEcCtD
Glyburide—Renal failure acute—Sorafenib—liver cancer	0.00102	0.0167	CcSEcCtD
Glyburide—CFTR—liver—liver cancer	0.00101	0.00802	CbGeAlD
Glyburide—Kidney function abnormal—Epirubicin—liver cancer	0.000992	0.0163	CcSEcCtD
Glyburide—Myelosuppression—Doxorubicin—liver cancer	0.000946	0.0155	CcSEcCtD
Glyburide—Hyponatraemia—Sorafenib—liver cancer	0.000945	0.0155	CcSEcCtD
Glyburide—Kidney function abnormal—Doxorubicin—liver cancer	0.000918	0.0151	CcSEcCtD
Glyburide—Glipizide—PPARG—liver cancer	0.00087	0.163	CrCbGaD
Glyburide—Blindness—Epirubicin—liver cancer	0.000866	0.0142	CcSEcCtD
Glyburide—ABCB11—liver—liver cancer	0.000826	0.00658	CbGeAlD
Glyburide—Blindness—Doxorubicin—liver cancer	0.000801	0.0131	CcSEcCtD
Glyburide—Pancreatitis—Sorafenib—liver cancer	0.000798	0.0131	CcSEcCtD
Glyburide—Eruption—Epirubicin—liver cancer	0.000779	0.0128	CcSEcCtD
Glyburide—SLC22A7—liver—liver cancer	0.000745	0.00593	CbGeAlD
Glyburide—Eruption—Doxorubicin—liver cancer	0.000721	0.0118	CcSEcCtD
Glyburide—Jaundice—Sorafenib—liver cancer	0.000707	0.0116	CcSEcCtD
Glyburide—Zafirlukast—CYP2E1—liver cancer	0.000643	0.121	CrCbGaD
Glyburide—Bezafibrate—PPARG—liver cancer	0.000635	0.119	CrCbGaD
Glyburide—SLC15A1—liver—liver cancer	0.000599	0.00477	CbGeAlD
Glyburide—Alopecia—Sorafenib—liver cancer	0.000576	0.00944	CcSEcCtD
Glyburide—Malnutrition—Sorafenib—liver cancer	0.000567	0.0093	CcSEcCtD
Glyburide—Erythema—Sorafenib—liver cancer	0.000567	0.0093	CcSEcCtD
Glyburide—Jaundice cholestatic—Epirubicin—liver cancer	0.000546	0.00895	CcSEcCtD
Glyburide—Hyperbilirubinaemia—Epirubicin—liver cancer	0.000527	0.00864	CcSEcCtD
Glyburide—ABCC3—liver—liver cancer	0.000526	0.00419	CbGeAlD
Glyburide—Anaemia—Sorafenib—liver cancer	0.000524	0.00859	CcSEcCtD
Glyburide—Angioedema—Sorafenib—liver cancer	0.000518	0.0085	CcSEcCtD
Glyburide—Leukopenia—Sorafenib—liver cancer	0.000508	0.00832	CcSEcCtD
Glyburide—Jaundice cholestatic—Doxorubicin—liver cancer	0.000505	0.00828	CcSEcCtD
Glyburide—SLCO2B1—liver—liver cancer	0.00049	0.0039	CbGeAlD
Glyburide—Hyperbilirubinaemia—Doxorubicin—liver cancer	0.000488	0.008	CcSEcCtD
Glyburide—Arthralgia—Sorafenib—liver cancer	0.000483	0.00792	CcSEcCtD
Glyburide—Myalgia—Sorafenib—liver cancer	0.000483	0.00792	CcSEcCtD
Glyburide—Shock—Sorafenib—liver cancer	0.000455	0.00747	CcSEcCtD
Glyburide—Nervous system disorder—Sorafenib—liver cancer	0.000454	0.00744	CcSEcCtD
Glyburide—Thrombocytopenia—Sorafenib—liver cancer	0.000453	0.00743	CcSEcCtD
Glyburide—SLCO1A2—liver—liver cancer	0.000451	0.00359	CbGeAlD
Glyburide—Aplastic anaemia—Epirubicin—liver cancer	0.00045	0.00738	CcSEcCtD
Glyburide—ALB—liver—liver cancer	0.000448	0.00357	CbGeAlD
Glyburide—Anorexia—Sorafenib—liver cancer	0.000441	0.00723	CcSEcCtD
Glyburide—Bezafibrate—CYP1A1—liver cancer	0.000429	0.0803	CrCbGaD
Glyburide—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000422	0.00691	CcSEcCtD
Glyburide—ABCC2—liver—liver cancer	0.00042	0.00335	CbGeAlD
Glyburide—Aplastic anaemia—Doxorubicin—liver cancer	0.000416	0.00683	CcSEcCtD
Glyburide—Dyspnoea—Sorafenib—liver cancer	0.000413	0.00677	CcSEcCtD
Glyburide—Dyspepsia—Sorafenib—liver cancer	0.000407	0.00668	CcSEcCtD
Glyburide—Decreased appetite—Sorafenib—liver cancer	0.000402	0.0066	CcSEcCtD
Glyburide—Gastrointestinal disorder—Sorafenib—liver cancer	0.0004	0.00655	CcSEcCtD
Glyburide—Hepatic function abnormal—Epirubicin—liver cancer	0.000398	0.00653	CcSEcCtD
Glyburide—Vascular purpura—Epirubicin—liver cancer	0.000389	0.00638	CcSEcCtD
Glyburide—Hepatic failure—Epirubicin—liver cancer	0.000387	0.00635	CcSEcCtD
Glyburide—Gastrointestinal pain—Sorafenib—liver cancer	0.000378	0.00621	CcSEcCtD
Glyburide—Renal failure acute—Epirubicin—liver cancer	0.000377	0.00618	CcSEcCtD
Glyburide—ABCC1—liver—liver cancer	0.00037	0.00295	CbGeAlD
Glyburide—Hepatic function abnormal—Doxorubicin—liver cancer	0.000368	0.00604	CcSEcCtD
Glyburide—Urticaria—Sorafenib—liver cancer	0.000368	0.00603	CcSEcCtD
Glyburide—Abdominal pain—Sorafenib—liver cancer	0.000366	0.006	CcSEcCtD
Glyburide—Renal impairment—Epirubicin—liver cancer	0.000366	0.006	CcSEcCtD
Glyburide—Dermatitis bullous—Epirubicin—liver cancer	0.000364	0.00597	CcSEcCtD
Glyburide—CYP2C19—liver—liver cancer	0.000361	0.00288	CbGeAlD
Glyburide—Purpura—Epirubicin—liver cancer	0.000361	0.00592	CcSEcCtD
Glyburide—Vascular purpura—Doxorubicin—liver cancer	0.00036	0.0059	CcSEcCtD
Glyburide—Hepatic failure—Doxorubicin—liver cancer	0.000358	0.00588	CcSEcCtD
Glyburide—Hypoglycaemia—Epirubicin—liver cancer	0.000357	0.00585	CcSEcCtD
Glyburide—Hyponatraemia—Epirubicin—liver cancer	0.000349	0.00573	CcSEcCtD
Glyburide—Renal failure acute—Doxorubicin—liver cancer	0.000349	0.00572	CcSEcCtD
Glyburide—Diplopia—Epirubicin—liver cancer	0.000348	0.00571	CcSEcCtD
Glyburide—Hypersensitivity—Sorafenib—liver cancer	0.000341	0.00559	CcSEcCtD
Glyburide—Renal impairment—Doxorubicin—liver cancer	0.000338	0.00555	CcSEcCtD
Glyburide—Dermatitis bullous—Doxorubicin—liver cancer	0.000337	0.00552	CcSEcCtD
Glyburide—Purpura—Doxorubicin—liver cancer	0.000334	0.00548	CcSEcCtD
Glyburide—Asthenia—Sorafenib—liver cancer	0.000332	0.00544	CcSEcCtD
Glyburide—Hypoglycaemia—Doxorubicin—liver cancer	0.00033	0.00541	CcSEcCtD
Glyburide—Pruritus—Sorafenib—liver cancer	0.000327	0.00537	CcSEcCtD
Glyburide—ABCB1—embryo—liver cancer	0.000327	0.0026	CbGeAlD
Glyburide—Hyponatraemia—Doxorubicin—liver cancer	0.000323	0.0053	CcSEcCtD
Glyburide—Diplopia—Doxorubicin—liver cancer	0.000322	0.00528	CcSEcCtD
Glyburide—Diarrhoea—Sorafenib—liver cancer	0.000317	0.00519	CcSEcCtD
Glyburide—ABCG2—liver—liver cancer	0.000306	0.00244	CbGeAlD
Glyburide—Gliclazide—ALB—liver cancer	0.000304	0.057	CrCbGaD
Glyburide—Abdominal distension—Epirubicin—liver cancer	0.000303	0.00497	CcSEcCtD
Glyburide—Eosinophilia—Epirubicin—liver cancer	0.000298	0.00488	CcSEcCtD
Glyburide—Pancreatitis—Epirubicin—liver cancer	0.000295	0.00484	CcSEcCtD
Glyburide—Vomiting—Sorafenib—liver cancer	0.000294	0.00483	CcSEcCtD
Glyburide—Rash—Sorafenib—liver cancer	0.000292	0.00479	CcSEcCtD
Glyburide—Dermatitis—Sorafenib—liver cancer	0.000292	0.00478	CcSEcCtD
Glyburide—Headache—Sorafenib—liver cancer	0.00029	0.00475	CcSEcCtD
Glyburide—Pancytopenia—Epirubicin—liver cancer	0.000286	0.00468	CcSEcCtD
Glyburide—Abdominal distension—Doxorubicin—liver cancer	0.00028	0.00459	CcSEcCtD
Glyburide—CYP2C9—liver—liver cancer	0.00028	0.00223	CbGeAlD
Glyburide—Eosinophilia—Doxorubicin—liver cancer	0.000276	0.00452	CcSEcCtD
Glyburide—Nausea—Sorafenib—liver cancer	0.000275	0.00451	CcSEcCtD
Glyburide—Photosensitivity reaction—Epirubicin—liver cancer	0.000275	0.0045	CcSEcCtD
Glyburide—Pancreatitis—Doxorubicin—liver cancer	0.000273	0.00447	CcSEcCtD
Glyburide—Pancytopenia—Doxorubicin—liver cancer	0.000264	0.00433	CcSEcCtD
Glyburide—Jaundice—Epirubicin—liver cancer	0.000261	0.00429	CcSEcCtD
Glyburide—Photosensitivity reaction—Doxorubicin—liver cancer	0.000254	0.00417	CcSEcCtD
Glyburide—Agranulocytosis—Epirubicin—liver cancer	0.00025	0.0041	CcSEcCtD
Glyburide—Jaundice—Doxorubicin—liver cancer	0.000242	0.00397	CcSEcCtD
Glyburide—Hepatitis—Epirubicin—liver cancer	0.000241	0.00395	CcSEcCtD
Glyburide—Visual impairment—Epirubicin—liver cancer	0.000232	0.0038	CcSEcCtD
Glyburide—Agranulocytosis—Doxorubicin—liver cancer	0.000232	0.0038	CcSEcCtD
Glyburide—Eye disorder—Epirubicin—liver cancer	0.000225	0.00369	CcSEcCtD
Glyburide—Hepatitis—Doxorubicin—liver cancer	0.000223	0.00365	CcSEcCtD
Glyburide—Visual impairment—Doxorubicin—liver cancer	0.000215	0.00352	CcSEcCtD
Glyburide—CYP3A4—liver—liver cancer	0.000213	0.0017	CbGeAlD
Glyburide—Alopecia—Epirubicin—liver cancer	0.000213	0.00349	CcSEcCtD
Glyburide—Erythema—Epirubicin—liver cancer	0.00021	0.00344	CcSEcCtD
Glyburide—Malnutrition—Epirubicin—liver cancer	0.00021	0.00344	CcSEcCtD
Glyburide—Eye disorder—Doxorubicin—liver cancer	0.000208	0.00341	CcSEcCtD
Glyburide—Vision blurred—Epirubicin—liver cancer	0.000197	0.00324	CcSEcCtD
Glyburide—Alopecia—Doxorubicin—liver cancer	0.000197	0.00323	CcSEcCtD
Glyburide—Malnutrition—Doxorubicin—liver cancer	0.000194	0.00318	CcSEcCtD
Glyburide—Erythema—Doxorubicin—liver cancer	0.000194	0.00318	CcSEcCtD
Glyburide—Anaemia—Epirubicin—liver cancer	0.000194	0.00318	CcSEcCtD
Glyburide—Leukopenia—Epirubicin—liver cancer	0.000188	0.00308	CcSEcCtD
Glyburide—Vision blurred—Doxorubicin—liver cancer	0.000183	0.003	CcSEcCtD
Glyburide—Convulsion—Epirubicin—liver cancer	0.000182	0.00298	CcSEcCtD
Glyburide—Anaemia—Doxorubicin—liver cancer	0.000179	0.00294	CcSEcCtD
Glyburide—Myalgia—Epirubicin—liver cancer	0.000178	0.00293	CcSEcCtD
Glyburide—Arthralgia—Epirubicin—liver cancer	0.000178	0.00293	CcSEcCtD
Glyburide—Leukopenia—Doxorubicin—liver cancer	0.000174	0.00285	CcSEcCtD
Glyburide—Confusional state—Epirubicin—liver cancer	0.000172	0.00283	CcSEcCtD
Glyburide—Oedema—Epirubicin—liver cancer	0.000171	0.0028	CcSEcCtD
Glyburide—Shock—Epirubicin—liver cancer	0.000168	0.00276	CcSEcCtD
Glyburide—Convulsion—Doxorubicin—liver cancer	0.000168	0.00275	CcSEcCtD
Glyburide—Nervous system disorder—Epirubicin—liver cancer	0.000168	0.00275	CcSEcCtD
Glyburide—Thrombocytopenia—Epirubicin—liver cancer	0.000167	0.00275	CcSEcCtD
Glyburide—Hyperhidrosis—Epirubicin—liver cancer	0.000165	0.00271	CcSEcCtD
Glyburide—Myalgia—Doxorubicin—liver cancer	0.000165	0.00271	CcSEcCtD
Glyburide—Arthralgia—Doxorubicin—liver cancer	0.000165	0.00271	CcSEcCtD
Glyburide—Anorexia—Epirubicin—liver cancer	0.000163	0.00267	CcSEcCtD
Glyburide—Hypotension—Epirubicin—liver cancer	0.00016	0.00262	CcSEcCtD
Glyburide—Confusional state—Doxorubicin—liver cancer	0.00016	0.00262	CcSEcCtD
Glyburide—Oedema—Doxorubicin—liver cancer	0.000158	0.0026	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000156	0.00256	CcSEcCtD
Glyburide—Shock—Doxorubicin—liver cancer	0.000156	0.00255	CcSEcCtD
Glyburide—Nervous system disorder—Doxorubicin—liver cancer	0.000155	0.00254	CcSEcCtD
Glyburide—Thrombocytopenia—Doxorubicin—liver cancer	0.000155	0.00254	CcSEcCtD
Glyburide—Paraesthesia—Epirubicin—liver cancer	0.000154	0.00252	CcSEcCtD
Glyburide—Hyperhidrosis—Doxorubicin—liver cancer	0.000153	0.00251	CcSEcCtD
Glyburide—Dyspnoea—Epirubicin—liver cancer	0.000152	0.0025	CcSEcCtD
Glyburide—ABCB1—liver—liver cancer	0.000151	0.0012	CbGeAlD
Glyburide—Anorexia—Doxorubicin—liver cancer	0.000151	0.00247	CcSEcCtD
Glyburide—Dyspepsia—Epirubicin—liver cancer	0.000151	0.00247	CcSEcCtD
Glyburide—Decreased appetite—Epirubicin—liver cancer	0.000149	0.00244	CcSEcCtD
Glyburide—Hypotension—Doxorubicin—liver cancer	0.000148	0.00242	CcSEcCtD
Glyburide—Gastrointestinal disorder—Epirubicin—liver cancer	0.000148	0.00242	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000144	0.00236	CcSEcCtD
Glyburide—Paraesthesia—Doxorubicin—liver cancer	0.000142	0.00233	CcSEcCtD
Glyburide—Dyspnoea—Doxorubicin—liver cancer	0.000141	0.00231	CcSEcCtD
Glyburide—Feeling abnormal—Epirubicin—liver cancer	0.000141	0.00231	CcSEcCtD
Glyburide—Gastrointestinal pain—Epirubicin—liver cancer	0.00014	0.00229	CcSEcCtD
Glyburide—Dyspepsia—Doxorubicin—liver cancer	0.000139	0.00228	CcSEcCtD
Glyburide—Decreased appetite—Doxorubicin—liver cancer	0.000138	0.00226	CcSEcCtD
Glyburide—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000137	0.00224	CcSEcCtD
Glyburide—Urticaria—Epirubicin—liver cancer	0.000136	0.00223	CcSEcCtD
Glyburide—Abdominal pain—Epirubicin—liver cancer	0.000135	0.00222	CcSEcCtD
Glyburide—Feeling abnormal—Doxorubicin—liver cancer	0.00013	0.00214	CcSEcCtD
Glyburide—Gastrointestinal pain—Doxorubicin—liver cancer	0.000129	0.00212	CcSEcCtD
Glyburide—Hypersensitivity—Epirubicin—liver cancer	0.000126	0.00207	CcSEcCtD
Glyburide—Urticaria—Doxorubicin—liver cancer	0.000126	0.00206	CcSEcCtD
Glyburide—Abdominal pain—Doxorubicin—liver cancer	0.000125	0.00205	CcSEcCtD
Glyburide—Asthenia—Epirubicin—liver cancer	0.000123	0.00201	CcSEcCtD
Glyburide—Pruritus—Epirubicin—liver cancer	0.000121	0.00198	CcSEcCtD
Glyburide—Diarrhoea—Epirubicin—liver cancer	0.000117	0.00192	CcSEcCtD
Glyburide—Hypersensitivity—Doxorubicin—liver cancer	0.000117	0.00191	CcSEcCtD
Glyburide—Asthenia—Doxorubicin—liver cancer	0.000114	0.00186	CcSEcCtD
Glyburide—Pruritus—Doxorubicin—liver cancer	0.000112	0.00184	CcSEcCtD
Glyburide—Vomiting—Epirubicin—liver cancer	0.000109	0.00178	CcSEcCtD
Glyburide—Diarrhoea—Doxorubicin—liver cancer	0.000108	0.00178	CcSEcCtD
Glyburide—Rash—Epirubicin—liver cancer	0.000108	0.00177	CcSEcCtD
Glyburide—Dermatitis—Epirubicin—liver cancer	0.000108	0.00177	CcSEcCtD
Glyburide—Headache—Epirubicin—liver cancer	0.000107	0.00176	CcSEcCtD
Glyburide—Nausea—Epirubicin—liver cancer	0.000102	0.00167	CcSEcCtD
Glyburide—Vomiting—Doxorubicin—liver cancer	0.000101	0.00165	CcSEcCtD
Glyburide—Rash—Doxorubicin—liver cancer	9.98e-05	0.00164	CcSEcCtD
Glyburide—Dermatitis—Doxorubicin—liver cancer	9.97e-05	0.00163	CcSEcCtD
Glyburide—Headache—Doxorubicin—liver cancer	9.91e-05	0.00163	CcSEcCtD
Glyburide—Nausea—Doxorubicin—liver cancer	9.4e-05	0.00154	CcSEcCtD
Glyburide—ABCC1—Metabolism—GSTM1—liver cancer	9.8e-06	6.46e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—GSTA1—liver cancer	9.78e-06	6.45e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—PIK3CG—liver cancer	9.74e-06	6.43e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	9.74e-06	6.42e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—PIK3CG—liver cancer	9.69e-06	6.39e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—NAT2—liver cancer	9.67e-06	6.38e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—MTHFR—liver cancer	9.62e-06	6.35e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—GSTA1—liver cancer	9.55e-06	6.3e-05	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	9.54e-06	6.29e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—GSTA4—liver cancer	9.48e-06	6.26e-05	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	9.46e-06	6.24e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PPARA—liver cancer	9.44e-06	6.23e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—NAT2—liver cancer	9.44e-06	6.22e-05	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—PIK3CB—liver cancer	9.39e-06	6.19e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—GSTP1—liver cancer	9.38e-06	6.19e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—PPARG—liver cancer	9.35e-06	6.16e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—liver cancer	9.3e-06	6.13e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—CYP1A1—liver cancer	9.29e-06	6.13e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PIK3CG—liver cancer	9.29e-06	6.12e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—ALDOB—liver cancer	9.27e-06	6.11e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	9.27e-06	6.11e-05	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—PIK3CA—liver cancer	9.26e-06	6.11e-05	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—PIK3CA—liver cancer	9.26e-06	6.11e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—HMOX1—liver cancer	9.25e-06	6.1e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—GSTA2—liver cancer	9.24e-06	6.1e-05	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—PIK3CB—liver cancer	9.1e-06	6e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—ALDOB—liver cancer	9.05e-06	5.97e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PPARG—liver cancer	8.96e-06	5.91e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—GSTA1—liver cancer	8.92e-06	5.88e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	8.87e-06	5.85e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CRABP1—liver cancer	8.84e-06	5.83e-05	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—PIK3CA—liver cancer	8.83e-06	5.82e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—NAT2—liver cancer	8.82e-06	5.82e-05	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	8.69e-06	5.73e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—APC—liver cancer	8.69e-06	5.73e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—MTHFR—liver cancer	8.66e-06	5.71e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CRABP1—liver cancer	8.63e-06	5.69e-05	CbGpPWpGaD
Glyburide—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	8.63e-06	5.69e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—GSTM1—liver cancer	8.62e-06	5.69e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—HPGDS—liver cancer	8.61e-06	5.68e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—PIK3CD—liver cancer	8.57e-06	5.65e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PPARG—liver cancer	8.56e-06	5.65e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—PIK3CD—liver cancer	8.51e-06	5.62e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PPARA—liver cancer	8.5e-06	5.6e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	8.48e-06	5.59e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	8.48e-06	5.59e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—SERPINE1—liver cancer	8.47e-06	5.59e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—ALDOB—liver cancer	8.45e-06	5.58e-05	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	8.41e-06	5.55e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—ALB—liver cancer	8.41e-06	5.54e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—CYP1A1—liver cancer	8.17e-06	5.39e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—BRAF—liver cancer	8.17e-06	5.39e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PIK3CD—liver cancer	8.16e-06	5.38e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PIK3CG—liver cancer	8.09e-06	5.33e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CRABP1—liver cancer	8.06e-06	5.32e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—ALB—liver cancer	8.06e-06	5.31e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	7.96e-06	5.25e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PPARG—liver cancer	7.8e-06	5.15e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	7.8e-06	5.14e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—HPGDS—liver cancer	7.73e-06	5.1e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—liver cancer	7.69e-06	5.07e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PSMD10—liver cancer	7.68e-06	5.06e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PSMA4—liver cancer	7.68e-06	5.06e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—RAF1—liver cancer	7.65e-06	5.04e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—PIK3CD—liver cancer	7.64e-06	5.04e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	7.63e-06	5.03e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—MTHFR—liver cancer	7.62e-06	5.03e-05	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—AKT1—liver cancer	7.57e-06	4.99e-05	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—AKT1—liver cancer	7.57e-06	4.99e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—SERPINE1—liver cancer	7.55e-06	4.98e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—HPGDS—liver cancer	7.55e-06	4.98e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PPARA—liver cancer	7.48e-06	4.93e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—GOT2—liver cancer	7.47e-06	4.92e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—PIK3CB—liver cancer	7.47e-06	4.92e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—PIK3CB—liver cancer	7.42e-06	4.89e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PIK3CG—liver cancer	7.28e-06	4.8e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	7.26e-06	4.79e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GLUL—liver cancer	7.21e-06	4.76e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CPT1B—liver cancer	7.21e-06	4.76e-05	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—AKT1—liver cancer	7.21e-06	4.76e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PIK3CB—liver cancer	7.12e-06	4.69e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PIK3CD—liver cancer	7.11e-06	4.69e-05	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	7.1e-06	4.68e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—HPGDS—liver cancer	7.05e-06	4.65e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PPARG—liver cancer	7.02e-06	4.63e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—CYP2E1—liver cancer	7.02e-06	4.63e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—ALB—liver cancer	7.02e-06	4.63e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	7.01e-06	4.62e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	7e-06	4.62e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—NR1H4—liver cancer	6.96e-06	4.59e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	6.91e-06	4.56e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PSMA4—liver cancer	6.89e-06	4.54e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PSMD10—liver cancer	6.89e-06	4.54e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—IL2—liver cancer	6.86e-06	4.52e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GSTA3—liver cancer	6.84e-06	4.51e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—RAF1—liver cancer	6.82e-06	4.5e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	6.8e-06	4.48e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PSMD10—liver cancer	6.73e-06	4.44e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PSMA4—liver cancer	6.73e-06	4.44e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—GOT2—liver cancer	6.7e-06	4.42e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—MTOR—liver cancer	6.66e-06	4.39e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—PIK3CB—liver cancer	6.66e-06	4.39e-05	CbGpPWpGaD
Glyburide—ALB—Transmembrane transport of small molecules—RAF1—liver cancer	6.62e-06	4.37e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—CYCS—liver cancer	6.57e-06	4.33e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—GOT2—liver cancer	6.54e-06	4.31e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—GOT1—liver cancer	6.45e-06	4.25e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—GGT1—liver cancer	6.45e-06	4.25e-05	CbGpPWpGaD
Glyburide—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	6.41e-06	4.23e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PIK3CG—liver cancer	6.4e-06	4.22e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PIK3CD—liver cancer	6.4e-06	4.22e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	6.38e-06	4.21e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—ALB—liver cancer	6.31e-06	4.16e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CYP2E1—liver cancer	6.3e-06	4.16e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	6.3e-06	4.16e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PSMA4—liver cancer	6.28e-06	4.14e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PSMD10—liver cancer	6.28e-06	4.14e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GSTA4—liver cancer	6.25e-06	4.13e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—CDKN1B—liver cancer	6.25e-06	4.12e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PIK3CB—liver cancer	6.2e-06	4.09e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PPARG—liver cancer	6.18e-06	4.08e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CYP2E1—liver cancer	6.15e-06	4.06e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—GOT2—liver cancer	6.11e-06	4.03e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	6.1e-06	4.02e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GSTA2—liver cancer	6.1e-06	4.02e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—CTNNB1—liver cancer	5.9e-06	3.89e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CYCS—liver cancer	5.9e-06	3.89e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GSTA1—liver cancer	5.88e-06	3.88e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—VEGFA—liver cancer	5.83e-06	3.84e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—NAT2—liver cancer	5.82e-06	3.84e-05	CbGpPWpGaD
Glyburide—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	5.8e-06	3.83e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—GSTP1—liver cancer	5.79e-06	3.82e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—GGT1—liver cancer	5.79e-06	3.82e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—GOT1—liver cancer	5.79e-06	3.82e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—CDKN1A—liver cancer	5.77e-06	3.8e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CYCS—liver cancer	5.76e-06	3.8e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CYP2E1—liver cancer	5.75e-06	3.79e-05	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—PIK3CA—liver cancer	5.72e-06	3.77e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—HMOX1—liver cancer	5.71e-06	3.77e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—GGT1—liver cancer	5.65e-06	3.72e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—GOT1—liver cancer	5.65e-06	3.72e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PIK3CD—liver cancer	5.63e-06	3.71e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ALDOB—liver cancer	5.58e-06	3.68e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PIK3CB—liver cancer	5.58e-06	3.68e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	5.56e-06	3.67e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—ALB—liver cancer	5.56e-06	3.66e-05	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—PIK3CA—liver cancer	5.55e-06	3.66e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CYCS—liver cancer	5.38e-06	3.55e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—TGFB1—liver cancer	5.35e-06	3.53e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—GSTM1—liver cancer	5.32e-06	3.51e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CRABP1—liver cancer	5.32e-06	3.51e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—GGT1—liver cancer	5.28e-06	3.48e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—GOT1—liver cancer	5.28e-06	3.48e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—GSTP1—liver cancer	5.2e-06	3.43e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—STAT3—liver cancer	5.14e-06	3.39e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—HMOX1—liver cancer	5.13e-06	3.38e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—GSTP1—liver cancer	5.07e-06	3.35e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—CYP1A1—liver cancer	5.04e-06	3.33e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—HMOX1—liver cancer	5e-06	3.3e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—KRAS—liver cancer	4.95e-06	3.27e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PIK3CB—liver cancer	4.91e-06	3.24e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—MYC—liver cancer	4.78e-06	3.15e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—GSTM1—liver cancer	4.78e-06	3.15e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—TGFB1—liver cancer	4.77e-06	3.15e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—GSTP1—liver cancer	4.74e-06	3.13e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—MTHFR—liver cancer	4.7e-06	3.1e-05	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—AKT1—liver cancer	4.68e-06	3.08e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—HMOX1—liver cancer	4.67e-06	3.08e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—GSTM1—liver cancer	4.66e-06	3.07e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—HPGDS—liver cancer	4.65e-06	3.07e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PPARA—liver cancer	4.61e-06	3.04e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—PIK3CA—liver cancer	4.55e-06	3e-05	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—AKT1—liver cancer	4.53e-06	2.99e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CYP1A1—liver cancer	4.53e-06	2.99e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—PIK3CA—liver cancer	4.52e-06	2.98e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CYP1A1—liver cancer	4.42e-06	2.91e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—KRAS—liver cancer	4.42e-06	2.91e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—TP53—liver cancer	4.4e-06	2.9e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—GSTM1—liver cancer	4.35e-06	2.87e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PIK3CA—liver cancer	4.34e-06	2.86e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—MTHFR—liver cancer	4.22e-06	2.78e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—HRAS—liver cancer	4.21e-06	2.78e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	4.14e-06	2.73e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PSMA4—liver cancer	4.14e-06	2.73e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PSMD10—liver cancer	4.14e-06	2.73e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PPARA—liver cancer	4.14e-06	2.73e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CYP1A1—liver cancer	4.13e-06	2.72e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—MTHFR—liver cancer	4.12e-06	2.72e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—PIK3CA—liver cancer	4.06e-06	2.68e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PPARA—liver cancer	4.04e-06	2.67e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GOT2—liver cancer	4.03e-06	2.66e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PIK3CG—liver cancer	3.95e-06	2.61e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—MTHFR—liver cancer	3.85e-06	2.54e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PPARG—liver cancer	3.81e-06	2.51e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CYP2E1—liver cancer	3.79e-06	2.5e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PIK3CA—liver cancer	3.78e-06	2.49e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PPARA—liver cancer	3.78e-06	2.49e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—HRAS—liver cancer	3.75e-06	2.48e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	3.72e-06	2.45e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—AKT1—liver cancer	3.72e-06	2.45e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—AKT1—liver cancer	3.7e-06	2.44e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—IL6—liver cancer	3.59e-06	2.37e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PIK3CG—liver cancer	3.55e-06	2.34e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CYCS—liver cancer	3.55e-06	2.34e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—AKT1—liver cancer	3.54e-06	2.34e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GOT1—liver cancer	3.48e-06	2.29e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GGT1—liver cancer	3.48e-06	2.29e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PIK3CD—liver cancer	3.47e-06	2.29e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PIK3CG—liver cancer	3.46e-06	2.28e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PPARG—liver cancer	3.42e-06	2.26e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PIK3CA—liver cancer	3.4e-06	2.24e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	3.39e-06	2.24e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PPARG—liver cancer	3.34e-06	2.2e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—AKT1—liver cancer	3.32e-06	2.19e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PIK3CG—liver cancer	3.23e-06	2.13e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GSTP1—liver cancer	3.13e-06	2.06e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PPARG—liver cancer	3.12e-06	2.06e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PIK3CD—liver cancer	3.12e-06	2.06e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—AKT1—liver cancer	3.09e-06	2.03e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—HMOX1—liver cancer	3.08e-06	2.03e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—ALB—liver cancer	3.08e-06	2.03e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PIK3CD—liver cancer	3.04e-06	2.01e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PIK3CB—liver cancer	3.03e-06	2e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—ALB—liver cancer	3e-06	1.98e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PIK3CA—liver cancer	2.99e-06	1.97e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GSTM1—liver cancer	2.87e-06	1.89e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PIK3CD—liver cancer	2.84e-06	1.87e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—ALB—liver cancer	2.81e-06	1.85e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—AKT1—liver cancer	2.78e-06	1.83e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CYP1A1—liver cancer	2.72e-06	1.8e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PIK3CB—liver cancer	2.72e-06	1.79e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PIK3CB—liver cancer	2.65e-06	1.75e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—MTHFR—liver cancer	2.54e-06	1.67e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PPARA—liver cancer	2.49e-06	1.64e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PIK3CB—liver cancer	2.48e-06	1.63e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—AKT1—liver cancer	2.44e-06	1.61e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PIK3CG—liver cancer	2.13e-06	1.41e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PPARG—liver cancer	2.06e-06	1.36e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PIK3CD—liver cancer	1.87e-06	1.24e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ALB—liver cancer	1.85e-06	1.22e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PIK3CA—liver cancer	1.85e-06	1.22e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PIK3CA—liver cancer	1.66e-06	1.09e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PIK3CB—liver cancer	1.63e-06	1.08e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PIK3CA—liver cancer	1.62e-06	1.07e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PIK3CA—liver cancer	1.51e-06	9.96e-06	CbGpPWpGaD
Glyburide—ALB—Metabolism—AKT1—liver cancer	1.51e-06	9.94e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—AKT1—liver cancer	1.35e-06	8.92e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—AKT1—liver cancer	1.32e-06	8.71e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—AKT1—liver cancer	1.23e-06	8.14e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PIK3CA—liver cancer	9.96e-07	6.57e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—AKT1—liver cancer	8.14e-07	5.37e-06	CbGpPWpGaD
